國立虎尾科技大學 |

Investigating Mechanisms of BAX Activation and Its Pharmacological Modulation Within the Mitochondrial Pathway of Apoptosis.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Investigating Mechanisms of BAX Activation and Its Pharmacological Modulation Within the Mitochondrial Pathway of Apoptosis./
作者:	Mohammed, Jarvier N.
面頁冊數:	1 online resource (329 pages)
附註:	Source: Dissertations Abstracts International, Volume: 85-07, Section: B.
Contained By:	Dissertations Abstracts International85-07B.
標題:	Biochemistry. -
電子資源:	click for full text (PQDT)
ISBN:	9798381402636

Investigating Mechanisms of BAX Activation and Its Pharmacological Modulation Within the Mitochondrial Pathway of Apoptosis.
Mohammed, Jarvier N.

Investigating Mechanisms of BAX Activation and Its Pharmacological Modulation Within the Mitochondrial Pathway of Apoptosis. - 1 online resource (329 pages)

Source: Dissertations Abstracts International, Volume: 85-07, Section: B.

Thesis (Ph.D.)--Icahn School of Medicine at Mount Sinai, 2024.

Includes bibliographical references

The mitochondrial pathway of apoptosis is critical to development, homeostasis, and cancer mechanisms; and is initiated following mitochondrial outer membrane permeabilization (MOMP). MOMP allows the release of mitochondrial apoptogenic proteins, which initiate a caspase cascade in the cytosol and organized cellular dismantling. The BCL-2 family is comprised of pro- and anti-apoptotic proteins and the balance of their physical interactions governs the decision to undergo MOMP.BAX is the critical pro-apoptotic BCL-2 effector protein, which forms proteolipid pores in the outer mitochondrial membrane (OMM), allowing for MOMP to occur. In response to cellular stress, BAX is activated and undergoes a continuum of conformational changes encompassing the transition from inactive, cytosolic monomer to oligomeric pore in the OMM. While key structural hallmarks of the BAX activation continuum have been identified, current technological limitations restrict dynamic interrogations into the intra-molecular rearrangements in BAX that occur prior to membrane localization. Anti-apoptotic BCL-2 proteins neutralize pro-death signals by actively sequestering their pro-apoptotic counterparts and are typically overexpressed in cancer cells to maintain survival. BH3 mimetics competitively bind the BC groove of the anti-apoptotic repertoire, imposing enhanced cellular sensitivity to subsequent apoptotic stimuli, but acquired resistance in cancer cells has limited their efficacy. The BC groove is conserved between BAX and the anti-apoptotic repertoire, and yet, BH3 mimetics were never tested against BAX.Techniques to qualitatively and quantitatively study BAX-mediated MOMP and apoptosis were developed using isolated organelles and high-content live-cell imagers. To interrogate BAX function at the molecular level, a kinetic assay to monitor BAX activation was developed and complementary techniques were used to advance perspectives within the field on BAX activation and its regulation by pharmacological agents. Using these concepts, BH3 mimetics were revealed to target the BC groove of multiple conformations of BAX and inhibit BAX-mediated membrane permeabilization by impeding translocation to membranes.This dissertation presents several approaches to study apoptosis from single molecules to isolated organelles to cells and encompasses a variety of techniques that not only provides novel insights in BAX biology but also proposes new considerations for BH3 mimetics and their impact on multiple BCL-2 family members.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798381402636Subjects--Topical Terms:

582831
Biochemistry.
Subjects--Index Terms:

ApoptosisIndex Terms--Genre/Form:

554714
Electronic books.

Investigating Mechanisms of BAX Activation and Its Pharmacological Modulation Within the Mitochondrial Pathway of Apoptosis.
LDR:04048ntm a22004337 4500 001 1148806
005 20240930100154.5
006 m o d
007 cr bn ---uuuuu
008 250605s2024 xx obm 000 0 eng d
020 $a 9798381402636
035 $a (MiAaPQ)AAI30989281
035 $a AAI30989281
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Mohammed, Jarvier N. $3 1474867
245 1 0 $a Investigating Mechanisms of BAX Activation and Its Pharmacological Modulation Within the Mitochondrial Pathway of Apoptosis.
264 0 $c 2024
300 $a 1 online resource (329 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-07, Section: B.
500 $a Advisor: Chipuk, Jerry Edward.
502 $a Thesis (Ph.D.)--Icahn School of Medicine at Mount Sinai, 2024.
504 $a Includes bibliographical references
520 $a The mitochondrial pathway of apoptosis is critical to development, homeostasis, and cancer mechanisms; and is initiated following mitochondrial outer membrane permeabilization (MOMP). MOMP allows the release of mitochondrial apoptogenic proteins, which initiate a caspase cascade in the cytosol and organized cellular dismantling. The BCL-2 family is comprised of pro- and anti-apoptotic proteins and the balance of their physical interactions governs the decision to undergo MOMP.BAX is the critical pro-apoptotic BCL-2 effector protein, which forms proteolipid pores in the outer mitochondrial membrane (OMM), allowing for MOMP to occur. In response to cellular stress, BAX is activated and undergoes a continuum of conformational changes encompassing the transition from inactive, cytosolic monomer to oligomeric pore in the OMM. While key structural hallmarks of the BAX activation continuum have been identified, current technological limitations restrict dynamic interrogations into the intra-molecular rearrangements in BAX that occur prior to membrane localization. Anti-apoptotic BCL-2 proteins neutralize pro-death signals by actively sequestering their pro-apoptotic counterparts and are typically overexpressed in cancer cells to maintain survival. BH3 mimetics competitively bind the BC groove of the anti-apoptotic repertoire, imposing enhanced cellular sensitivity to subsequent apoptotic stimuli, but acquired resistance in cancer cells has limited their efficacy. The BC groove is conserved between BAX and the anti-apoptotic repertoire, and yet, BH3 mimetics were never tested against BAX.Techniques to qualitatively and quantitatively study BAX-mediated MOMP and apoptosis were developed using isolated organelles and high-content live-cell imagers. To interrogate BAX function at the molecular level, a kinetic assay to monitor BAX activation was developed and complementary techniques were used to advance perspectives within the field on BAX activation and its regulation by pharmacological agents. Using these concepts, BH3 mimetics were revealed to target the BC groove of multiple conformations of BAX and inhibit BAX-mediated membrane permeabilization by impeding translocation to membranes.This dissertation presents several approaches to study apoptosis from single molecules to isolated organelles to cells and encompasses a variety of techniques that not only provides novel insights in BAX biology but also proposes new considerations for BH3 mimetics and their impact on multiple BCL-2 family members.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Biochemistry. $3 582831
650 4 $a Pharmacology. $3 583819
650 4 $a Oncology. $3 593951
650 4 $a Cellular biology. $3 1148666
653 $a Apoptosis
653 $a BAX
653 $a BCL-2 family
653 $a Cancer
653 $a Membrane permeabilization
653 $a Therapeutics
653 $a Outer mitochondrial membrane
655 7 $a Electronic books. $2 local $3 554714
690 $a 0379
690 $a 0992
690 $a 0487
690 $a 0419
710 2 $a Icahn School of Medicine at Mount Sinai. $b Cancer Biology. $3 1474868
710 2 $a ProQuest Information and Learning Co. $3 1178819
773 0 $t Dissertations Abstracts International $g 85-07B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30989281 $z click for full text (PQDT)